Renling Yao - Publications

Incidence and determinants of achieving HBsAg <100 IU/mL in HBeAg-negative CHB patients with nucleos(t)ide analogue treatment.

Journal: Emerging microbes & infections

Published: September 17, 2025

Profiles of quantitative hepatitis B surface antigen in patients with chronic hepatitis B.

Journal: Gut

Published: September 08, 2025

Association between serum HBV DNA levels and liver fibrosis in chronic hepatitis B.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: September 08, 2025

Antiviral Therapy Reduces Hepatocellular Carcinoma and Cirrhosis Risk in Chinese Chronic Hepatitis B Patients With Mildly Elevated Alanine Aminotransferase.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: August 29, 2025

Extreme gradient boosting-based explainable machine learning model for predicting significant fibrosis in autoimmune hepatitis.

Journal: QJM : monthly journal of the Association of Physicians

Published: April 06, 2025

Comprehensive analysis of chronic hepatitis B concurrent with non-alcoholic fatty liver disease: a proteomics report based on clinical liver samples.

Journal: Clinical proteomics

Published: December 21, 2023

NAFLD is associated with less severe liver fibrosis in chronic hepatitis B: A multi-center, retrospective study.

Journal: Annals of hepatology

Published: June 12, 2023

Scanning electron microscopic observation of the external morphology of Dermatophagoides farinae at different developmental stages

Journal: Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control

Published: May 10, 2022

Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores.

Journal: Journal of clinical laboratory analysis

Published: March 29, 2021

Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients.

Journal: Alimentary pharmacology & therapeutics

Published: March 29, 2019